Rocket


Overview
Financials
News + Filings
Key Docs
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Dermata Therapeutics, Inc. Create: Alert

All | News | Filings
Date FiledTypeDescription
08/10/2023 8-K Quarterly results
Docs: "Dermata Therapeutics Provides Corporate Update and Reports Second Quarter 2023 Financial Results"
08/10/2023 10-Q Quarterly Report for the period ended June 30, 2023
08/03/2023 8-K Changes in Registrant's Certifying Accountant, Departure of Directors or Certain Officers; Election of Directors; Appointment...
Docs: "Second Amendment to the Dermata Therapeutics, Inc. 2021 Omnibus Equity Incentive Plan",
"Letter of Mayer Hoffman McCann P.C. to the Securities and Exchange Commission"
07/28/2023 EFFECT Form EFFECT - Notice of Effectiveness:
07/27/2023 424B4 Form 424B4 - Prospectus [Rule 424(b)(4)]:
07/12/2023 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
07/07/2023 S-1 Form S-1 - General form for registration of securities under the Securities Act of 1933:
06/12/2023 D Form D - Notice of Exempt Offering of Securities:
06/01/2023 SC 13G INTRACOASTAL CAPITAL, LLC reports a 5% stake in Dermata Therapeutics, Inc.
05/25/2023 424B5 Form 424B5 - Prospectus [Rule 424(b)(5)]:
05/24/2023 8-K Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Regulation FD Disclosure, Financial Stat...
Docs: "Form of Pre-Funded Warrant",
"Form of Warrant",
"Form of Placement Agent Warrant",
"Opinion of Lowenstein Sandler LLP",
"Form of Securities Purchase Agreement, by and between the Company and the Purchasers",
"Dermata Therapeutics Announces $1.8 Million Offering Priced At-The-Market Under Nasdaq Rules"
05/11/2023 10-Q Quarterly Report for the period ended March 31, 2023
05/11/2023 8-K Quarterly results
Docs: "Dermata Therapeutics Provides Corporate Update and Reports First Quarter 2023 Financial Results"
03/31/2023 SC 13D/A HALE DAVID F reports a 1.9% stake in Dermata Therapeutics, Inc.
03/28/2023 8-K Quarterly results
03/20/2023 424B3 Form 424B3 - Prospectus [Rule 424(b)(3)]:
03/20/2023 8-K Quarterly results
03/20/2023 424B4 Form 424B4 - Prospectus [Rule 424(b)(4)]:
03/17/2023 EFFECT Form EFFECT - Notice of Effectiveness:
03/16/2023 S-1/A Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
03/13/2023 S-1/A Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
03/13/2023 8-K Material Modifications to Rights of Security Holders, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Yea...
Docs: "CERTIFICATE"
03/01/2023 S-1 Form S-1 - General form for registration of securities under the Securities Act of 1933:
02/08/2023 8-K Quarterly results
01/18/2023 SC 13D/A Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
01/13/2023 DEF 14A Form DEF 14A - Other definitive proxy statements:
01/03/2023 PRE 14A Form PRE 14A - Other preliminary proxy statements:
12/29/2022 RW Form RW - Registration Withdrawal Request:
12/15/2022 8-K Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Other Events ...
12/05/2022 8-K Regulation FD Disclosure, Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "Dermata Announces Topline Results from DMT310 Phase 2 Clinical Trial for the Treatment of Moderate-to-Severe Rosacea"
11/28/2022 EFFECT Form EFFECT - Notice of Effectiveness:
11/15/2022 S-3 Form S-3 - Registration statement under Securities Act of 1933:
09/23/2022 8-K Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits  ...
Docs: "Amendment to Amended and Restated Bylaws"
08/26/2022 S-8 Form S-8 - Securities to be offered to employees in employee benefit plans:
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy